KRS Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Buy |
+2,585
| New | +$202K | 0.14% | 108 |
|
|
2024
Q3 | – | Sell |
-2,735
| Closed | -$253K | – | 119 |
|
|
2024
Q2 | $253K | Hold |
2,735
| – | – | 0.19% | 101 |
|
|
2024
Q1 | $261K | Sell |
2,735
-365
| -12% | -$34.9K | 0.21% | 101 |
|
|
2023
Q4 | $236K | Sell |
3,100
-480
| -13% | -$36.6K | 0.22% | 104 |
|
|
2023
Q3 | $248K | Sell |
3,580
-345
| -9% | -$23.9K | 0.26% | 93 |
|
|
2023
Q2 | $370K | Buy |
3,925
+100
| +3% | +$9.43K | 0.37% | 75 |
|
|
2023
Q1 | $316K | Hold |
3,825
| – | – | 0.36% | 82 |
|
|
2022
Q4 | $285K | Buy |
3,825
+200
| +6% | +$14.9K | 0.39% | 82 |
|
|
2022
Q3 | $299K | Buy |
3,625
+20
| +0.6% | +$1.65K | 0.41% | 73 |
|
|
2022
Q2 | $342K | Hold |
3,605
| – | – | 0.49% | 69 |
|
|
2022
Q1 | $424K | Buy |
3,605
+50
| +1% | +$5.88K | 0.46% | 64 |
|
|
2021
Q4 | $460K | Buy |
+3,555
| New | +$460K | 0.39% | 66 |
|